Expertise in
4
conditions

Jacques Hugon

Paris, FR 
Expertise in
4
conditions
Paris, FR 

Overview

Jacques Hugon practices practicing medicine in Paris, France.

Mr. Hugon is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Alzheimer's Disease, Dementia, Long Haul COVID, and Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy.

He is actively involved in clinical research, co-authoring 195 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Paris, France
Other Locations
La Seyne-sur-mer, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Longitudinal Study of Brain Amyloid imaGing in MEMENTO
Longitudinal Study of Brain Amyloid imaGing in MEMENTO
Enrollment Status: Completed
Publish Date: February 03, 2022
Intervention Type: Drug
Study Drugs: Flutemetamol, Florbetapir
Study Phase: Phase 3
MEMENTO-VAScular COmponents of Dementia
MEMENTO-VAScular COmponents of Dementia
Enrollment Status: Completed
Publish Date: January 28, 2022
Intervention Type: Other
Study Phase: Not Applicable
A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Aducanumab (BIIB037) in Subjects With Early Alzheimer's Disease
A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Aducanumab (BIIB037) in Subjects With Early Alzheimer's Disease
Enrollment Status: Terminated
Publish Date: September 02, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 2 Less Clinical Trials

194 Total Publications

Eligibility for lecanemab treatment in a French memory clinic setting.
Eligibility for lecanemab treatment in a French memory clinic setting.
Journal: Journal of neurology
Published: January 09, 2026

Frequently Asked Questions about Jacques Hugon

Is Jacques Hugon a top-rated expert for Alzheimer's Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Jacques Hugon is classified as an Distinguished expert for Alzheimer's Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jacques Hugon participate in research or clinical trials?

Yes. Jacques Hugon has published 194 articles and abstracts on conditions like Alzheimer's Disease. You can view a list of Jacques Hugon's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Hugon's expertise for a condition
ConditionClose
    View All 18 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile